Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Thrombosis and Hemostasis Centers Research and Prevention Network, Request for Applications (RFA) DD07-004 and RFA DD07-005, 11363-11364 [E7-4533]

Download as PDF 11363 Federal Register / Vol. 72, No. 48 / Tuesday, March 13, 2007 / Notices Trans # Acquiring Acquired Entities 20070766 ......................... 20070767 ......................... Ahmass Fakahany ............................. Robert McCann ................................. Merrill Lynch & Co., Inc ..................... Merrill Lynch & Co., Inc ..................... Merrill Lynch & Co., Inc. Merrill Lynch & Co., Inc. Transactions Granted Early Termination—02/26/2007 20070713 ......................... Park Avenue Equity Partners II, L.P Donald L. Besecker, Jr. and Laura M. Besecker. 20070717 ......................... Park Avenue Equity Partners II, L.P George E. Marucci, Jr ....................... 20070726 ......................... 20070731 ......................... Onex Partners II LP .......................... International Business Machines Corporation. West Corporation .............................. West Corporation .............................. Eastman Kodak Company ................ Softek Storage Holdings, Inc ............ Pennmark Auto Group II, Pennmark Auto Group IV, Pennmark Auto Group, LP. Pennmark Auto Group II, Pennmark Auto Group IV, Pennmark Auto Group, LP. Eastman Kodak Company. Softek Storage Holdings, Inc. Richland Ventures III, LP .................. Neil and Fran Smith Armentrout ....... TeleVox Software, Inc. TeleVox Software, Inc. 20070741 ......................... 20070742 ......................... L.P., LP, L.P., LP, Transactions Granted Early Termination—02/27/2007 20070681 ......................... LS Power Equity Partners II, L.P ...... Mirant Corporation ............................. 20070750 ......................... 20070770 ......................... 20070772 ......................... Safelite Group, Inc ............................ AKQA, Inc .......................................... Educate, Inc ...................................... 20070774 ......................... 20070785 ......................... 20070786 ......................... s.a. D’leteren n.v ............................... General Atlantic Partners 83, L.P ..... Edge Acquisition, LLC c/o Sterling Capital Partners LLC. Audax Private Equity Fund, L.P ........ Carlyle Partners IV, L.P .................... Imperial Tobacco Group PLC ........... 20070787 ......................... The Bear Stearns Companies Inc ..... 20070793 ......................... Ralcorp Holdings, Inc ........................ 20070794 ......................... Ralcorp Holdings, Inc ........................ 20070798 ......................... Babcock & Brown Wind Partners Limited. Fraser Papers, Inc ............................. Aurora Equity Partners III L.P ........... 20070805 ......................... 20070806 ......................... Industrial Growth Partners II, L.P ...... Philosophy, Inc .................................. Houchens Industries, Inc. ESOP and Trust. Progress Energy, Inc ......................... Harold B. Rothman and Wendi F. Rothman. William R. Ross ................................. Babcock & Brown Limited ................. Partners Limited ................................ Hellman & Friedman Capital Partners IV, L.P. Mirant Las Vegas, LLC, Mirant Sugar Creek, LLC, Mirant Texas, LP, Mirant Zeeland, LLC, Shady Hills Power Company, L.L.C., West Georgia Generating Company, L.L.C. Safelite Group, Inc. AKQA, Inc. Educate, Inc. TASI Holdings, Inc. Philosophy, Inc. CBHC, Inc. Ceredo Synfuel LLC, Sandy River Synfuel LLC, Solid Energy LLC, Solid Fuel LLC. Bloomfield Bakers L.P., Lovin Oven, LLC. Bloomfield Bakers L.P., Lovin Oven, LLC. B&B Wind Portfolio. Katahdin Holdings LLC. Mitchell International Holding, Inc. Transactions Granted Early Termination—03/01/2007 20070728 ......................... 20070734 ......................... 20070788 ......................... Allied Capital Corporation ................. Carlyle/Riverstone Global Energy and Power Fund III, L.P. Paul G. Desmarais ............................ cprice-sewell on PROD1PC66 with NOTICES For Further Information Contact: Sandra M. Peay, Contact Representative, or Renee Hallman, Contact Representative, Federal Trade Commission, Premerger Notification Office, Bureau of Competition, Room H– 303, Washington, DC 20580, (202) 326– 3100. By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 07–1165 Filed 3–12–07; 8:45 am] 14:58 Mar 12, 2007 Direct Capital Corporation. Titan GP, LLC, Titan Specialties, Ltd. March & McLennan Companies, Inc Putnam Investments Trust. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Thrombosis and Hemostasis Centers Research and Prevention Network, Request for Applications (RFA) DD07–004 and RFA DD07–005 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) BILLING CODE 6750–01–M VerDate Aug<31>2005 Direct Capital Corporation ................. TSI Delaware, Inc .............................. Jkt 211001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 announces the following meeting of the aforementioned SEP: Time and Date: 12 p.m.–4 p.m., May 3, 2007 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of scientific merit of grant applications received in response to RFAs DD07–004 and DD07–005, ‘‘Thrombosis and Hemostasis Centers Research and Prevention Network.’’ E:\FR\FM\13MRN1.SGM 13MRN1 11364 Federal Register / Vol. 72, No. 48 / Tuesday, March 13, 2007 / Notices For Further Information Contact: Christine Morrison, Ph.D., Scientific Review Administrator, Centers for Disease Control and Prevention, 1600 Clifton Road NE., Mailstop D72, Atlanta, GA 30333, Telephone 404.639.3098. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–4533 Filed 3–12–07; 8:45 am] Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): The National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) Arthritis Program Programmatic Review cprice-sewell on PROD1PC66 with NOTICES In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 8 a.m.–5 p.m., April 24, 2007 (Closed). Place: Renaissance Hotel, 590 W. Peachtree Street NW., Atlanta, GA 30308, telephone 404–881–6000. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of the NCCDPHP Arthritis Program. For Further Information Contact: Lee Ann B. Ramsey, Designated Federal Official, Division of Adult and Community Health, CDC, 4770 Buford Hwy. NE., Mailstop K51, Atlanta, GA 30341, Telephone 770–488– 6036. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Jkt 211001 BILLING CODE 4163–18–P Draft Final Guidance for Industry: Guide to Minimize Food Safety Hazards for Fresh-Cut Fruits and Vegetables; Availability; Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Food and Drug Administration [Docket No. 2006D–0079] AGENCY: Food and Drug Administration, HHS. The National Center for Environmental Health (NCEH) of the Centers for Disease Control and Prevention (CDC) Vessel Sanitation Program (VSP) announces the following meeting: DEPARTMENT OF HEALTH AND HUMAN SERVICES 14:58 Mar 12, 2007 DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of Annual Meeting BILLING CODE 4163–18–P VerDate Aug<31>2005 Dated: March 2, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–4537 Filed 3–12–07; 8:45 am] ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the availability of a draft final guidance document entitled ‘‘Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Fresh-Cut Fruits Name: Vessel Sanitation Program: Current and Vegetables’’ (the draft final fresh-cut Program Status and Experience to Date with Program Operations. guidance). This document complements Time and Date: 9 a.m. to 4 p.m., April 17, FDA’s Current Good Manufacturing 2007. Practice (CGMP) requirements for foods Location: Auditorium, Port Everglades by providing specific guidance on the Administration Building, 1850 Eller Drive, processing of fresh-cut produce. The Ft. Lauderdale, Florida 33316. draft final fresh-cut guidance and the Status: Open to the public, limited by the CGMP regulations are intended to assist space available. The meeting room processors in minimizing microbial food accommodates approximately 100 people. safety hazards common to the Meeting Objectives: CDC staff, cruise ship processing of most fresh-cut fruits and industry representatives, private sanitation vegetables sold to consumers and retail consultants, and other interested parties will meet to discuss the current status of the establishments in a ready-to-eat form. Vessel Sanitation Program and experience to FDA also is announcing that a proposed date. collection of information has been Topics to be discussed include but are not submitted to the Office of Management limited to the following: and Budget (OMB) for review and • 2006 Program Review, clearance under the Paperwork • Updates to the Vessel Sanitation Program Reduction Act of 1995 (the PRA). Operations Manual 2005, • Updates to the Vessel Sanitation Program DATES: Submit written or electronic comments on the guidance at any time. Construction Guidelines 2005, and • Updates on cruise ship outbreaks and Fax written comments on the collection Norovirus. of information by April 12, 2007. The official record of this meeting will ADDRESSES: To ensure that comments on remain open for a period of 15 days following the information collection are received, the meeting (through May 1, 2007) so that OMB recommends that written additional materials or comments may be comments be faxed to the Office of submitted and made part of the record of the Information and Regulatory Affairs, meeting. OMB, Attn: FDA Desk Officer, FAX: Advanced registration is encouraged. 202–395–6974. Submit written requests Please provide the following information: Name, title, company name, mailing address, for single copies of the draft final telephone number, facsimile number, and eguidance entitled: ‘‘Guidance for mail address to Lisa Beaumier at 770–488– Industry: Guide to Minimize Microbial 7138, FAX 770–488–4127, or Food Safety Hazards for Fresh-Cut lbeaumier@cdc.gov. Fruits and Vegetables’’ to the Center for If you need additional information, please Food Safety and Applied Nutrition, contact Lisa Beaumier (see contact Office of Plant and Dairy Foods (HFS– information above). 306), 5100 Paint Branch Pkwy., College Dated: March 5, 2007. Park, MD 20740, 301–436–1400 or FAX: James D. Seligman, 301–436–2651. Include a self-addressed Chief Information Officer, Centers for Disease adhesive label to assist that office in Control and Prevention. processing your request. [FR Doc. E7–4530 Filed 3–12–07; 8:45 am] Submit written comments on the draft final guidance, identified with Docket BILLING CODE 4163–18–P PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\13MRN1.SGM 13MRN1

Agencies

[Federal Register Volume 72, Number 48 (Tuesday, March 13, 2007)]
[Notices]
[Pages 11363-11364]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-4533]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Thrombosis and Hemostasis Centers Research and 
Prevention Network, Request for Applications (RFA) DD07-004 and RFA 
DD07-005

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
SEP:

    Time and Date: 12 p.m.-4 p.m., May 3, 2007 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of scientific merit of grant applications 
received in response to RFAs DD07-004 and DD07-005, ``Thrombosis and 
Hemostasis Centers Research and Prevention Network.''

[[Page 11364]]

    For Further Information Contact: Christine Morrison, Ph.D., 
Scientific Review Administrator, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE., Mailstop D72, Atlanta, GA 30333, 
Telephone 404.639.3098.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-4533 Filed 3-12-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.